» Articles » PMID: 17628425

Prevalence of Unsuspected and Significant Mitral and Aortic Regurgitation

Overview
Specialty Radiology
Date 2007 Jul 14
PMID 17628425
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We sought to determine the prevalence of unsuspected, pre-existing valvular regurgitation in a large, heterogeneous population of patients referred for an echocardiogram.

Methods: The echocardiograms of 6851 consecutive individuals without suspected valve disease were reviewed. Regurgitant severity was graded using a clinical composite of published methods and multiple logistic analyses were used to model various clinical variables.

Results: The overall prevalence of moderate or greater mitral regurgitation (MR) was 11.7% in male patients and 12.5% in female patients. For mild or greater aortic insufficiency (AI), the prevalence was 18.9% in male patients and 19.7% in female patients. Both MR and AI increased exponentially as a function of age. Female sex predicted MR, but AI was sex neutral. Regurgitant severity increased with decreasing ejection fraction and body mass index, a history of hypertension, the presence of left ventricular hypertrophy, and valvular abnormalities.

Conclusions: The prevalence of unsuspected MR and AI is substantial, increases exponentially with age, and is predicted by commonly used clinical variables.

Citing Articles

Aortic regurgitation is associated with African American and Asian race, smoking, renal disease, and numerous autoimmune diseases in addition to traditional cardiovascular risk factors but has lower risk with alcohol intake.

Timmerman B, Hashemzadeh M, Movahed M Clin Res Cardiol. 2024; .

PMID: 38478089 DOI: 10.1007/s00392-024-02424-3.


Transcatheter Edge-to-Edge Repair for a Patient With Severe Mitral Regurgitation of Carpentier IIIa Classification.

Liu H, Lai H, Liu C, Wang C, Chen Y, Wei H JACC Case Rep. 2023; 18:101911.

PMID: 37545672 PMC: 10401062. DOI: 10.1016/j.jaccas.2023.101911.


Sex Differences in Epidemiology, Morphology, Mechanisms, and Treatment of Mitral Valve Regurgitation.

Tersalvi G, Gaiero L, Capriolo M, Cristoforetti Y, Salizzoni S, Senatore G Medicina (Kaunas). 2023; 59(6).

PMID: 37374220 PMC: 10304487. DOI: 10.3390/medicina59061017.


Expert proposal to analyze the combination of aortic and mitral regurgitation in multiple valvular heart disease by comprehensive echocardiography.

Hagendorff A, Helfen A, Brandt R, Knebel F, Altiok E, Ewers A Clin Res Cardiol. 2023; 113(3):393-411.

PMID: 37212864 PMC: 10881739. DOI: 10.1007/s00392-023-02227-y.


Incidence of heart valve disease in women treated with the ergot-derived dopamine agonist bromocriptine.

Clausen M, Rorth R, Torp-Pedersen C, Westergaard L, Weeke P, Gislason G BMC Cardiovasc Disord. 2021; 21(1):622.

PMID: 34963443 PMC: 8714426. DOI: 10.1186/s12872-021-02439-y.